Oculotix
AI‑powered ophthalmic diagnostics platform for early, quantitative detection of vision‑threatening diseases.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Estimated funding: $15M
AI Company Overview
AI‑powered ophthalmic diagnostics platform for early, quantitative detection of vision‑threatening diseases.
Ophthalmology
Technology Platform
Proprietary deep‑learning platform that analyzes fundus and OCT images to deliver quantitative disease severity scores and visual heatmaps for retinal disorders.
Opportunities
Rapid growth of AI‑driven ophthalmic screening and tele‑health integration offers scalable market expansion and licensing revenue.
Risk Factors
Regulatory approval timelines, data privacy compliance, and competition from larger AI diagnostics firms could impede commercialization.
Competitive Landscape
Competes with IDx, Eyenuk, and Google DeepMind’s eye‑care AI, differentiating via dual‑modality imaging and explainable AI outputs.